Literature DB >> 30058611

The Comparison of Perventricular Device Closure with Transcatheter Device Closure and the Surgical Repair via Median Sternotomy for Perimembranous Ventricular Septal Defect.

Guan-Hua Fang1, Qiang Chen1, Zhi-Nuan Hong1, Ze-Wei Lin1, Gui-Can Zhang1, Hua Cao1, Liang-Wan Chen1.   

Abstract

BACKGROUND: Perventricular and transcatheter device closures are performed for perimembranous ventricular septal defect (pmVSD) to reduce the surgical trauma of conventional surgical repair via median sternotomy. Few comparative studies have been conducted among these three procedures.
METHODS: From June 2015 to May 2016, 247 patients with isolated pmVSD who had undergone perventricular or transcatheter device closure or conventional surgical repair were reviewed to compare these three procedures.
RESULTS: The procedure success rate was similar in these three groups. There were a statistically significant difference in operative time, aortic cross-clamping time, duration of cardiopulmonary bypass (CPB), blood transfusion amount, and medical cost in these three groups. Meanwhile, postoperative mechanical ventilation time, duration of intensive care, and length of hospital stay were longer in surgical group than the other two groups. The surgical group required the longest incision. No significant difference was noted in major adverse events. There were different advantages and disadvantages in these three kinds of procedures.
CONCLUSIONS: Device closure may be alternative to conventional surgical repair for patients with isolated pmVSD. Perventricular device closure was the preferred procedure because it showed more maneuverable than transcatheter procedure with the same clinical result.

Entities:  

Keywords:  congenital heart diseases; perventricular devices occlusions; surgery; transcatheter; ventricular septal defect

Mesh:

Year:  2018        PMID: 30058611      PMCID: PMC6300419          DOI: 10.5761/atcs.oa.18-00085

Source DB:  PubMed          Journal:  Ann Thorac Cardiovasc Surg        ISSN: 1341-1098            Impact factor:   1.520


  6 in total

1.  Transthoracic closure of ventricular septal defects guided by transesophageal echocardiography.

Authors:  Huang Jiang-Shan; Sun Kai-Peng; Xu Ning; Zhang Gui-Can; Chen Qiang
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2020-04-22       Impact factor: 0.332

2.  Minimally-invasive-perventricular-device-occlusion versus surgical-closure for treating perimembranous-ventricular-septal-defect: 3-year outcomes of a multicenter randomized clinical trial.

Authors:  Wenxin Lu; Fengwen Zhang; Taibing Fan; Tianli Zhao; Yu Han; Xiaopeng Hu; Qi Li; Hao Shi; Xiangbin Pan
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

3.  Comparisons of perventricular device closure, conventional surgical repair, and transcatheter device closure in patients with perimembranous ventricular septal defects: a network meta-analysis.

Authors:  Dongxu Li; Xu Zhou; Mengsi Li; Qi An
Journal:  BMC Surg       Date:  2020-05-26       Impact factor: 2.102

4.  Health-related quality of life in children and adolescents undergoing intraoperative device closure of isolated perimembranous ventricular septal defects in southeastern China.

Authors:  Jiang-Shan Huang; Shu-Ting Huang; Kai-Peng Sun; Zhi-Nuan Hong; Liang-Wan Chen; Yur-Ren Kuo; Qiang Chen
Journal:  J Cardiothorac Surg       Date:  2019-12-16       Impact factor: 1.637

5.  Minimally invasive closure of transthoracic ventricular septal defect: postoperative complications and risk factors.

Authors:  Chunnian Ren; Chun Wu; Zhengxia Pan; Yonggang Li
Journal:  J Cardiothorac Surg       Date:  2021-03-19       Impact factor: 1.637

6.  Hybrid Transthoracic Periventricular Device Closure of Ventricular Septal Defects: Single- Center Experience.

Authors:  Liying Wu; Ibrahim Cansaran Tanidir; DongTing Ye; Xiong Zhang; Bin Li; Daliang Zhu; Gaopi Deng; Haisheng Chen
Journal:  Braz J Cardiovasc Surg       Date:  2021-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.